Universität zu Köln

Linz, Charlotte ORCID: 0009-0006-2777-4905, Shimabukuro-Vornhagen, Alexander ORCID: 0000-0002-2351-7294, Hesse, Nina, Probst, Lucie, Garcia Borrega, Jorge ORCID: 0000-0003-1326-1560, Eichenauer, Dennis A. ORCID: 0000-0002-1927-3514, Kochanek, Matthias ORCID: 0000-0002-4766-4651, von Bergwelt-Baildon, Michael and Böll, Boris ORCID: 0000-0002-6432-0981 (2025). Prediction of Hyperinflammatory Phenotypes in Critically Ill Patients via Routine Clinical Data and IL-6: Towards Personalized Anti-Inflammatory Therapy. International Journal of Molecular Sciences, 26 (20). MDPI. ISSN 1422-0067

Storck, Anthea, Beutel, Gernot, Kochanek, Matthias ORCID: 0000-0002-4766-4651, Schellongowski, Peter, Staudinger, Thomas, Buchtele, Nina, Cserna, Julia, Brueder, Nicole, Lueck, Catherina, Liebregts, Tobias, Tzalavras, Asterios, Hammersen, Jakob, Kroschinsky, Frank, Forkert, Randolf, Kiehl, Michael G., von Bergwelt-Baildon, Michael, Grans-Sibel, Judit, Bach, Franziska, Borrega, Jorge Garcia ORCID: 0000-0003-1326-1560, Naendrup, Jan-Hendrik ORCID: 0000-0002-6420-7938, Shimabukuro-Vornhagen, Alexander ORCID: 0000-0002-2351-7294, Eichenauer, Dennis A. ORCID: 0000-0002-1927-3514 and Böll, Boris ORCID: 0000-0001-6097-5238 (2025). Targeted antineoplastic therapy in critically ill cancer patients: a multicenter analysis of the iCHOP registry. Annals of Hematology, 104 (5). pp. 2937-2946. Springer Nature. ISSN 0939-5555

Rosenbrock, Johannes ORCID: 0000-0003-3340-0556, Kaul, Helen, Oertel, Michael, Celik, Eren, Linde, Philipp ORCID: 0000-0002-2813-1331, Fan, Jiaqi, Eichenauer, Dennis A. ORCID: 0000-0002-1927-3514, Bröckelmann, Paul J. ORCID: 0000-0001-9662-9900, von Tresckow, Bastian ORCID: 0000-0003-1410-4487, Kobe, Carsten ORCID: 0000-0002-2909-0826, Dietlein, Markus ORCID: 0000-0003-0992-6099, Fuchs, Michael ORCID: 0000-0003-3289-3272, Borchmann, Peter ORCID: 0000-0003-3782-2158, Eich, Hans Theodor and Baues, Christian (2024). Involved-site Radiation Therapy is Equally Effective and Less Toxic Than Involved-field Radiation Therapy in Patients Receiving Combined Modality Treatment for Early-stage Unfavorable Hodgkin Lymphoma—An Analysis of the Randomized Phase 3 HD17 Trial of the German Hodgkin Study Group. International journal of radiation oncology, biology, physics, 120 (5). pp. 1344-1352. Elsevier Science. ISSN 0360-3016

Kühne, Lucas ORCID: 0000-0002-5990-0279, Völker, Linus A. ORCID: 0000-0002-4461-6128, Hagmann, Henning, Hägele, Holger, Osterholt, Thomas ORCID: 0000-0001-5047-0252, Eichenauer, Dennis A. ORCID: 0000-0002-1927-3514, Thomas, Andreas, Breuer, Johanna, Grüttner, Berthold, Gottschalk, Ingo, Kann, Martin, Benzing, Thomas ORCID: 0000-0003-0512-1066, Thevis, Mario, Müller, Annette M. and Brinkkötter, Paul T. ORCID: 0000-0002-4287-2080 (2022). First use of the anti‐VWF nanobody caplacizumab to treat iTTP in pregnancy. British Journal of Haematology, 196 (3). e30-e33. Wiley-Blackwell. ISSN 0007-1048

Eichenauer, Dennis A. ORCID: 0000-0002-1927-3514, Golla, Heidrun ORCID: 0000-0002-4403-630X, Thielen, Indra, Hallek, Michael ORCID: 0000-0002-7425-4455, Voltz, Raymond ORCID: 0000-0002-4761-3395 and Perrar, Klaus Maria (2019). Characteristics and course of patients with advanced hematologic malignancies receiving specialized inpatient palliative care at a German university hospital. Annals of Hematology, 98 (11). pp. 2605-2607. Springer Nature. ISSN 0939-5555